- Corporate
- For Print
- May 18, 2026
鶹 Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “鶹”) announced today that it was selected for the first time as “SX Brands 2026,” a designation jointly selected by the Ministry of Economy, Trade and Industry (METI) and the Tokyo Stock Exchange (TSE).

SX (Sustainability Transformation) is an initiative to promote management and business transformation focused on sustainable growth through constructive dialogue with stakeholders, including investors, while addressing mid- to long-term risks and business opportunities arising from social sustainability issues as important corporate challenges. The "SX Brands" selection is a joint initiative by the METI and the TSE to recognize and publicize a group of pioneering companies that enhance their ability to sustainably generate growth resources through SX, thereby increasing corporate value. Launched in 2024, the “SX Brands 2026” marks the third year of the initiative, with a total of 15 companies selected this year.
鶹 was recognized for its commitment to maximizing its intrinsic corporate value over the medium to long term. Under its corporate concept, 鶹 defines this value as the sum of “social impact*” and “financial value” generated through addressing social issues, such as dementia, cancer, and global health. The reasons for the selection include 鶹's incorporation of ecosystem development into its business model by collaborating with corporations and local municipalities to provide pharmaceutical and non-pharmaceutical solutions across various life stages, from daily living to medical/nursing care. Furthermore, the selection was based on its constructive engagement with investors based on clearly defined mid-term plans and KPIs, as well as its highly transparent capital policy, which have been highly evaluated by the market.
鶹’s Corporate Concept is to give first thought to patients and people in the daily living domain, and to increase the benefits that health care provides. Under this Concept also known as our human health care (hhc) Concept, we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. Through further enhancing sustainability and achieving social good, 鶹 will continue to increase corporate value and further contribute to increasing the benefits of patients and the people in the daily living domain.
* 鶹’s intrinsic corporate value (representing various positive impacts on society) that is not reflected in its sales revenues and profits, quantified in monetary terms.
Media Inquiries:
Public Relations Department,
鶹 Co., Ltd.
+81-(0)3-3817-5120
Our news releases are intended to disclose corporate information and are not intended for the promotion or advertising of prescription pharmaceuticals or investigational products, nor are they intended to provide medical advice.
Please note that the information contained in news releases is current as of the date of publication.